Clinical Trials Logo

BCT Rate clinical trials

View clinical trials related to BCT Rate.

Filter by:
  • None
  • Page 1

NCT ID: NCT01929811 Terminated - Safety Clinical Trials

NeoMET Study in Neoadjuvant Treatment of Breast Cancer

NeoMET
Start date: October 2013
Phase: Phase 2
Study type: Interventional

To evaluate docetaxel, epirubicin and cyclophosphomide (TEC) with TEC plus metformin in neoadjuvant treatment of breast cancer patients. The aim is to evaluate whether metformin can increase the pCR rate combination with TEC regimen in neoadjuvant setting.